ADENOVIRUS E1A FRAGMENTS FOR USE IN ANTI-CANCER THERAPIES
摘要
The present invention relates to an improved cancer therapy comprising co-administration with the El A 1-80 transcription-repression domain activity. In addition, El A 1-80 can act as a monotherapy against cancers that express elevated HER2/Neu or in combination with anti-HER2/Neu, chemo- or radiotherapeutic treatments.
申请公布号
WO2013012922(A1)
申请公布日期
2013.01.24
申请号
WO2012US47198
申请日期
2012.07.18
申请人
SAINT LOUIS UNIVERSITY;GREEN, MAURICE;LOEWENSTEIN, PAUL, M.